Elevated levels of clozapine in serum after addition of fluvoxamine

Journal of Clinical Psychopharmacology

Volumn 14, Issue 4, 1994, Pages 279-281

  Hiemke, Christoph ^a   Weigmann, Harald ^a   Härtter, Sebastian ^a   Dahmen, Norbert ^a   Wetzel, Hermann ^a   Müller, Hildegard ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; DRUG METABOLITE; FLUVOXAMINE; HALOPERIDOL; PERAZINE;

ADULT; CASE REPORT; DEPRESSION; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG METABOLISM; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; LETTER; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SCHIZOPHRENIA; VERTIGO;

ADULT; CASE REPORT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHRONIC DISEASE; CLOZAPINE; DRUG THERAPY, COMBINATION; FEMALE; FLUVOXAMINE; HUMAN; MALE; METABOLIC CLEARANCE RATE; SCHIZOPHRENIA, PARANOID; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0028016505     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/00004714-199408000-00011     Document Type: Letter

References (20)

1. Baldessarini RJ, Frankenburg FR. Clozapine A novel antipsychotic agent. N Engl J Med 1991;324:746–54.
2. Naber D, Holzbach R, Perro C, Hippius H. Clirical management of clozapine patients in relation to efficacy and side-effects. Br J Psychiatry 1992;160(suppl 17):54–9.
3. Jann MW, Grimsley SR, Gray EC, Chang WH. Pharmacokinetics and pharmacodynamics of clozapine. Clin Pharmacokinet 1993;24:161–76.
4. Goff DC, Brotman AW, Waites M, McCormick S. Trial of fluoxetine added to neuroleptics for treatment-resistant schizophrenic patients. Am J Psychiatry 1990;147:492–4.
5. Weigmann H, Hiemke C. Determination of clozapine and its major metabolites in human serum using automated solid-phase extraction and subsequent isocratic high-performance liquid chromatography with ultraviolet detection. J Chromatogr 1992;583:209–16.
6. Cassady SL, Thaker GK. Addition of fluoxetine to clozapine. Am J Psychiatry 1992; 149:1274.
7. Goumniouk AD, Ancill RJ, MacEwan GW, Koczapski AB. A case of drug-drug interaction involving clozapine. Can J Psychiatry 1991;36:234–5.
8. KOnig P, Kunz A. Compatibility of clozapine and chloroquine. Lancet 1991;338:948.
9. Miller DD. Effect of phenytoin on plasma clozapine concentrations in two patients. J Clin Psychiatry 1991;52:23–5.
10. Raitasuo V, Lehtovaara R, Huttunen MO. Carbamazepine and plasma levels of clozapine. Am J Psychiatry 1993; 150:169.
11. Szymanski S, Lieberman JA, Picou D, Masiar S, Cooper MA. A case report of cimetidine-induced clozapine toxicity. J Clin Psychiatry 1991;52:21–2.
12. Perry PJ, Miller DD, Arndt SV, Cadoret RJ. Clozapine and norclozapine plasma concentrations and clinical response of treatmentrefractory schizophrenic patients. Am J Psychiatry 1991; 148:231–5.
13. Bondesson U, LindstrOm LH. Determination of clozapine and its N-demethylated metabolite in plasma by use of gas chromatography-mass spectrometry with single ion detection. Psychopharmacology 1988;95:472–5.
14. Volpicelli SA, Centorrino F, Puopolo PR, Kando J, Frankenburg FR, Baldessarini RJ. Determination of clozapine, norclozapine, and clozapine-N-oxide in serum by liquid chromatography. Clin Chem 1993;39:1656–9.
15. Cholerton S, Daly AK, Idle JR. The role of individual human cytochromes P450 in drug metabolism and clinical response. Trends Pharmacol 1992;13:434–9.
16. Fischer V, Vogels B, Maurer G, Tynes RE, The antipsychotic clozapine is metabolized by the polymorphic human microsomal and recombinant cytochrome P450 2D6. J Pharmacol Exp Ther 1992;280:1355–60.
17. SKjelbo E, Brosen K. Inhibitors of imipraniine metabolism by human liver microsomes. Br J Clin Pharma 1992;34:256–61.
18. Brosen K, Skjelbo E, Rasmussen BB, Poulsen HE, Loft S. Fluvoxamine is a potent inhibitor of cytochrome P4501A2. Biochem Pharmacol 1993;45:1211–4.
19. Bertschy G, Vandel S, Vandel G, Allers G, Volmat R. Fluvoxainine tricyclic antidepressant interaction. Eur J Clin Pharmacol 1991;40:119–20.
20. Hartter S, Wetzel H, Hammes E, Hiemke C. Inhibition of antidepressant demethylation and hydroxylation by fluvoxamine in depressed patients. Psychopharmacology 1993;100:302–8.